ARWR — Arrowhead Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $8.26bn
- $7.92bn
- $829.45m
Brief: Arrowhead Pharmaceuticals Q2 EPS USD -0.93
Brief: Arrowhead Pharmaceuticals - Licenses Aro-Pnpla3 To Madrigal Pharmaceuticals
U.S. RESEARCH ROUNDUP- Caterpillar, Textron, Wesco International
Arrowhead Pharmaceuticals misses Q1 revenue estimates
Brief: Arrowhead Pharmaceuticals Q1 EPS USD 0.22
ADT rises ahead of S&P SmallCap addition
U.S. STOCKS ON THE MOVE.-CoreWeave, Texas Instruments, Richtech Robotics
Arrowhead rises as it begins trial of high-cholesterol disorder drug
Brief: Arrowhead Pharmaceuticals - Issues $700 Million Of 0.00% Convertible Notes Due 2032 - SEC Filing
U.S. STOCKS ON THE MOVE-DoorDash, Duolingo, Gap
U.S. STOCKS ON THE MOVE-Bloom Energy, Tyson Foods, Voyager Technologies
Arrowhead Pharma rises after upsized $825 mln raise
Brief: Arrowhead Pharmaceuticals Offers 3,100,776 Shares At $64.50 Per Share
U.S. STOCKS ON THE MOVE-Nvidia, Boeing, Lowe's
U.S. STOCKS ON THE MOVE-Netflix, Alumis, Micron Technology
U.S. STOCKS ON THE MOVE-Hershey, Praxis Precision, Cal-Maine Foods
Brief: Arrowhead Pharmaceuticals Announces Nmpa Approval Of Redemplo® (Plozasiran)
Arrowhead Pharma slips after unveiling convertible, stock deals
U.S. RESEARCH ROUNDUP-Alphabet, Hershey, Micron Technology